These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20123937)

  • 21. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor.
    Koo BN; Kim MK; Yang J; Min KT
    Neurosci Lett; 2009 Nov; 465(2):147-50. PubMed ID: 19765401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response.
    Blier P
    J Psychiatry Neurosci; 2001; 26 Suppl(Suppl):S3-10. PubMed ID: 11590967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microarray analysis in drug discovery: an uplifting view of depression.
    Levy SE
    Sci STKE; 2003 Oct; 2003(206):pe46. PubMed ID: 14583588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant treatment and rodent aggressive behaviour.
    Mitchell PJ
    Eur J Pharmacol; 2005 Dec; 526(1-3):147-62. PubMed ID: 16289453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5HT3 receptors: Target for new antidepressant drugs.
    Gupta D; Prabhakar V; Radhakrishnan M
    Neurosci Biobehav Rev; 2016 May; 64():311-25. PubMed ID: 26976353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response.
    Dremencov E; Weizmann Y; Kinor N; Gispan-Herman I; Yadid G
    Curr Drug Targets; 2006 Feb; 7(2):165-75. PubMed ID: 16475958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underlying mechanisms mediating the antidepressant effects of estrogens.
    Osterlund MK
    Biochim Biophys Acta; 2010 Oct; 1800(10):1136-44. PubMed ID: 19900508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: a reciprocal risk factor for depression and insulin resistance?
    Pomytkin IA; Cline BH; Anthony DC; Steinbusch HW; Lesch KP; Strekalova T
    Behav Brain Res; 2015 Jan; 276():111-7. PubMed ID: 24815315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models.
    Renoir T; Pang TY; Lanfumey L
    Neurosci Biobehav Rev; 2012 Jan; 36(1):696-726. PubMed ID: 22037449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local injections of serotonin type-3 receptor antagonists as a therapeutic option in rheumatology.
    Seidel MF
    Future Med Chem; 2012 Apr; 4(6):705-7. PubMed ID: 22530634
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetes-associated depression: the serotonergic system as a novel multifunctional target.
    Prabhakar V; Gupta D; Kanade P; Radhakrishnan M
    Indian J Pharmacol; 2015; 47(1):4-10. PubMed ID: 25821303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurobiology of the EEG biomarker as a predictor of treatment response in depression.
    Baskaran A; Milev R; McIntyre RS
    Neuropharmacology; 2012 Sep; 63(4):507-13. PubMed ID: 22569197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT
    Bhatt S; Devadoss T; Manjula SN; Rajangam J
    Curr Neuropharmacol; 2021; 19(9):1545-1559. PubMed ID: 33059577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel therapeutic targets in depression: minocycline as a candidate treatment.
    Soczynska JK; Mansur RB; Brietzke E; Swardfager W; Kennedy SH; Woldeyohannes HO; Powell AM; Manierka MS; McIntyre RS
    Behav Brain Res; 2012 Dec; 235(2):302-17. PubMed ID: 22963995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fresh approaches to antidepressant drug discovery.
    Anacker C
    Expert Opin Drug Discov; 2014 Apr; 9(4):407-21. PubMed ID: 24588262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.